COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

KRS Global Blog

23

September
2014

category:

503b Compounding

Hospira Issues a Voluntary Nationwide Recall

Hospira initiated a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with an expiration date of 01NOV 2015. This action is due to one confirmed customer report of particulate in a single unit. […]

read more

23

September
2014

category:

503b Compounding

Sun Pharmaceutical’s woes deepen as US arm Taro recalls Warfarin from markets

MUMBAI: Sun Pharma’s recall worries continue with its American subsidiary Taro recalling its leading blood clot drug from the market after the USFDA found that the product did not meet its quality norms. Taro has recalled Warfarin Sodium after the USFDA faulted its poor quality. This is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in […]

read more

23

September
2014

category:

503b Compounding

Canadians kept in dark about defective drugs

North American patients have been put at risk by prescription drugs that Canadian pharmaceutical companies sold with knowledge that their products were defective, a Star investigation has found. Using records obtained through U.S. freedom of information laws, the Star also found other Canadian companies have: Hidden, altered and in some cases destroyed test data that […]

read more